Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough?
@article{JTD40183, author = {Christopher Lemmon and Nathan A. Pennell}, title = {Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough?}, journal = {Journal of Thoracic Disease}, volume = {12}, number = {9}, year = {2020}, keywords = {}, abstract = {}, issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/40183} }